Growing competitors from Microsoft Teams, combined with a difficult macroenvironment, might cause a lot more discomfort for Zoom Video investors, according toCiti Analyst Tyler Radke reduced Zoom to sell/high danger from neutral/high danger. He likewise cut his cost target ahead of its revenues report next week. “Zoom’s post-COVID growth trajectory has always been more challenging, given pullforward dynamics, but we see new hurdles to sustaining growth including rising competition (MSFT/Teams), macro-related weakness hitting SMB and less critical spending categories and margin risk,” Radke composed in a Tuesday note. “Although new SKUs such as Phone are promising, we believe increasing churn in SMB/online, and rising competition in Enterprise will more than offset new product strength and drive estimates below consensus,” he included. Shares of Zoom struggled this year as the video teleconferencing business stopped working to sustain momentum from its pandemic highs, when Americans embraced the software application to from another location participate in conferences. The stock is off 38% this year and more than 68% listed below its 52- week high. Radke anticipates the stock will fall even more from here. The expert decreased the cost target to $91 from $99, indicating almost 20% drawback from Monday’s closing cost of $11323 Shares dropped more than 3% in Tuesday premarket trading. “We are making significant estimate cuts with our revised revenue and FCF estimates 8% and 17% below the street in FY24E. Our model forecasts revenue growth slowing into MSD next year, with FCF declining as a result of ongoing investments and working capital. We believe shares have downside given the +43% move off recent lows and trading at 21x our revised FY24 EV/FCF estimate,” he included. Still, Morgan Stanley experts thought about Zoom positively ahead of its revenues next week, mentioning operating take advantage of “likely to drive upside on bottom line even as growth normalizes post-COVID.”– CNBC’s Michael Bloom added to this report.